1. Home
  2. Live Updates
  3. Laurie sehn

Live Breaking News & Updates on Laurie sehn

Stay informed with the latest breaking news from Laurie sehn on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Laurie sehn and stay connected to the pulse of your community

Unmet Needs in Treating Relapsed/Refractory FL

Laurie Sehn, MD, and Bijal Shah, MD, discuss remaining unmet needs for patients with relapsed/refractory FL.

Bijal-shah , Laurie-sehn , Recent-updates , Follicular-lymphoma , Mantle-cell-lymphoma , Fl , Ctdna , Pod-24 , Ezh2 , Tumor-microenvironment , Immunotherapy

Zanubrutinib as Third-Line and Beyond Therapy for FL

Laurie Sehn, MD, discusses recent data on zanubrutinib, a BTK inhibitor, as third-line and beyond therapy for FL.

Laurie-sehn , Recent-updates , Follicular-lymphoma , Mantle-cell-lymphoma , Beyond-therapy , Fl , Zanubrutinib , Third-line-therapy , Third-line-and-beyond , Obinutuzumab , Durable-response

High Rate of Durable Responses in R/R Lymphoma With Bispecific Antibody

Response rate exceeds 60%, with 15- to 20-month duration with epcoritamab

Texas , United-states , Vancouver , British-columbia , Canada , United-kingdom , Houston , Michigan , Ann-arbor , British , Laurie-sehn , Charles-bankhead

Health Canada Authorizes POLIVY® (polatuzumab vedotin for injection) for the First-Line Treatment of Adults With Large B-Cell Lymphoma

In Canada, it is estimated that in 2022, 11,400 Canadians will be diagnosed with non-Hodgkin lymphoma1, of which 30-40% of cases are diffuse large B-cell...

United-kingdom , Canada , Quebec , Canadians , British , Canadian , Antonella-rizza , Amy-haddlesey , Laurie-sehn , World-health-organization-classification-of-haematolymphoid-tumours , Lymphoma-society-of-canada , Bc-cancer-centre-for-lymphoid

Multiple Myeloma: Isatuximab as Add-On to RVd Induction Improves MRD Negativity

Multiple Myeloma: Isatuximab as Add-On to RVd Induction Improves MRD Negativity
physiciansweekly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from physiciansweekly.com Daily Mail and Mail on Sunday newspapers.

Germany , Heidelberg , Baden-wüberg , United-states , United-kingdom , American , British , Peggy-peck , Laurie-sehn , Hartmut-goldschmidt , American-society-of-hematology , British-columbia-cancer-centre-for-lymphoid

CAR T-Cell Therapy Makes Strong Case for Earlier Use in Lymphoma

Large increases in event-free survival with two CAR T-cell products in second line

Colorado , United-states , Florida , Tampa , United-kingdom , Vancouver , British-columbia , Canada , American , British , Manali-kamdar , Charles-bankhead

Isatuximab Added to RVd Boosts Response in New Myeloma

The addition of the anti-CD38 antibody improved minimal residual disease rates at the end of induction, a marker for better outcomes following autologous stem cell transplant.

Canada , Germany , United-states , Missouri , Vancouver , British-columbia , Heidelberg , Baden-wüberg , Washington-university , Siteman-cancer-center , American , Laurie-sehn

New Studies Highlight How Immunotherapies Are Transforming Care for Blood Cancers

/PRNewswire/ -- Four studies being presented during the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition point to the transformative...

Colorado , United-states , Germany , California , Heidelberg , Baden-wüberg , United-kingdom , Washington , American , British , Manali-kamdar , L-elizabeth-budde

New Studies Highlight How Immunotherapies Are Transforming Care for Blood Cancers

/PRNewswire/ -- Four studies being presented during the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition point to the transformative...

Colorado , United-states , Germany , California , Heidelberg , Baden-wüberg , United-kingdom , Washington , American , British , Manali-kamdar , L-elizabeth-budde

'Remarkable' Results With CAR T Cells Could Make Chemo Obsolete

Chemotherapy, the decades-old approach to second-line therapy for relapsed/refractory large B cell lymphomas, may soon be obsolete, investigators say.

Colorado , United-states , Florida , Tampa , Canada , Vancouver , British-columbia , American , Manali-kamdar , Frederickl-locke , Laurie-sehn , American-society-of-hematology